RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy
2022-01-01 Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R.
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience
2008-01-01 De Sanctis, R; Cerbone, L; Sacco, Pc; Sollami, R; Fulvi, A; Petrelli, E; Girolami, M; Bianco, V; Longo, F; Di Seri, M
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US).
2009-01-01 De Sanctis, R; Quadrini, S; Stumbo, L; Gori, B; Del Signore, E; Adua, D; Recine, F; De Filippis, L; Longo, F; Di Seri, M
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US).
2009-01-01 Quadrini, S; De Sanctis, R; Stumbo, L; Gori, B; Del Signore, E; De Filippis, L; Ricci, P; Cantisani, V; Di Seri, M; Longo, F
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC
2008-01-01 Gori, B; Longo, F; Zivi, A; De Sanctis, R; Del Signore, E; Proietti, E; Sperduti, I; De Filippis, L; Stumbo, L; Quadrini, S; Di Seri, M
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma
2009-01-01 De Sanctis, R; Quadrini, S; Tedeschi, M; Stumbo, L; Gori, B; Del Signore, E; Ricci, P; Cantisani, V; Di Seri, M; Longo, F
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy
2009-01-01 Quadrini, S; Longo, F; Lapadula, V; Stumbo, L; De Sanctis, R; D’Antoni, I; Del Signore, E; Gori, B; Viggiani, E; Vairanom, ; Di Seri, M
First-line chemotherapy in over-70 patients with colon cancer.
2007-01-01 Raimondi, C; Rosati, Ms; Bianco, V; Graziano, V; Stumbo, L; Recine, F; Restuccia, M; De Sanctis, R; Giovannoni, S; Di Seri, M
Imatinib mesylate in desmoplastic small round cell tumour
2012-01-01 Bertuzzi, A; Bisogno, G; Carli, M; Ferrari, A; Comandone, A; Gasco, M; De Sanctis, R; Gnocchi, C; Santoro, A
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T).
2013-01-01 De Sanctis, R; Quagliuolo, V; Viganò, A; Lutman, Fr; Bertuzzi, Af; Marchetti, S; Zucali, Pa; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy | 1-gen-2022 | Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R. | |
| Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience | 1-gen-2008 | De Sanctis, R; Cerbone, L; Sacco, Pc; Sollami, R; Fulvi, A; Petrelli, E; Girolami, M; Bianco, V; Longo, F; Di Seri, M | |
| Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). | 1-gen-2009 | De Sanctis, R; Quadrini, S; Stumbo, L; Gori, B; Del Signore, E; Adua, D; Recine, F; De Filippis, L; Longo, F; Di Seri, M | |
| Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). | 1-gen-2009 | Quadrini, S; De Sanctis, R; Stumbo, L; Gori, B; Del Signore, E; De Filippis, L; Ricci, P; Cantisani, V; Di Seri, M; Longo, F | |
| Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC | 1-gen-2008 | Gori, B; Longo, F; Zivi, A; De Sanctis, R; Del Signore, E; Proietti, E; Sperduti, I; De Filippis, L; Stumbo, L; Quadrini, S; Di Seri, M | |
| Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma | 1-gen-2009 | De Sanctis, R; Quadrini, S; Tedeschi, M; Stumbo, L; Gori, B; Del Signore, E; Ricci, P; Cantisani, V; Di Seri, M; Longo, F | |
| Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy | 1-gen-2009 | Quadrini, S; Longo, F; Lapadula, V; Stumbo, L; De Sanctis, R; D’Antoni, I; Del Signore, E; Gori, B; Viggiani, E; Vairanom, ; Di Seri, M | |
| First-line chemotherapy in over-70 patients with colon cancer. | 1-gen-2007 | Raimondi, C; Rosati, Ms; Bianco, V; Graziano, V; Stumbo, L; Recine, F; Restuccia, M; De Sanctis, R; Giovannoni, S; Di Seri, M | |
| Imatinib mesylate in desmoplastic small round cell tumour | 1-gen-2012 | Bertuzzi, A; Bisogno, G; Carli, M; Ferrari, A; Comandone, A; Gasco, M; De Sanctis, R; Gnocchi, C; Santoro, A | |
| Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). | 1-gen-2013 | De Sanctis, R; Quagliuolo, V; Viganò, A; Lutman, Fr; Bertuzzi, Af; Marchetti, S; Zucali, Pa; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ... 28
- 4 Contributo in Atti di Convegno ... 12
- 4 Contributo in Atti di Convegno ... 10
- 4 Contributo in Atti di Convegno ... 6
Data di pubblicazione
- 2020 - 2022 1
- 2010 - 2019 10
- 2007 - 2009 17
Editore
- Oxford University Press 3
- OXFORD UNIV PRESS, GREAT CLARENDO... 2
- OXFORD UNIV PRESS 1
Rivista
- ANNALS OF ONCOLOGY 21
- JOURNAL OF CLINICAL ONCOLOGY 4
- EUROPEAN JOURNAL OF CANCER 1
- EUROPEAN JOURNAL OF CANCER. SUPPL... 1
Lingua
- eng 7
Accesso al fulltext
- no fulltext 26
- reserved 2